PHARMA-BIO SERV, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8 USD | +6.67% |
|
-6.76% | -23.81% |
Financials (USD)
| Sales 2024 * | 12.8M | Sales 2025 * | 20.2M | Capitalization | 18.37M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.44 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.91 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 100 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.4% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +6.67% | ||
| 1 week | -6.76% | ||
| Current month | -5.55% | ||
| 1 month | -4.88% | ||
| 3 months | -23.81% | ||
| 6 months | -13.04% | ||
| Current year | -23.81% |
1 week
0.65
0.80
1 month
0.650.89
Current year
0.651.08
1 year
0.651.10
3 years
0.581.34
5 years
0.582.34
10 years
0.332.34
| Managers | Title | Age | Since |
|---|---|---|---|
Victor Sanchez
CEO | Chief Executive Officer | 53 | 10-12-31 |
Pedro Lasanta
DFI | Director of Finance/CFO | 64 | 07-11-04 |
Sandra Molina
COO | Chief Operating Officer | - | 10-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dov Perlysky
BRD | Director/Board Member | 61 | 03-12-31 |
Kirk Michel
CHM | Chairman | 68 | 06-01-24 |
Howard Spindel
BRD | Director/Board Member | 78 | 06-01-24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 0.8 | +6.67% | 7,000 |
| 24-04-17 | 0.75 | -12.59% | 14,159 |
Delayed Quote OTC Markets, April 18, 2024 at 09:36 am EDT
More quotes
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
Sector
Business Support Services
Calendar
2024-06-11
- Q2 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.81% | 18.37M | |
| +4.26% | 7.25B | |
| +2.98% | 2.58B | |
| +8.23% | 1.78B | |
| -10.98% | 1.07B | |
| +29.89% | 896M | |
| -10.18% | 722M | |
| -1.32% | 620M | |
| -4.56% | 579M | |
| -25.39% | 495M |
- Stock Market
- Equities
- PBSV Stock
